Yangtze River Pharmaceutical Group Pharmaceutical

Founded in 1971, Yangtze River Pharmaceutical Group (hereinafter referred to as YRPG) is a Chinese giant pharmaceutical group listed by Ministry of Science and Technology as one of the first Innovative Enterprises of China. YRPG, headquartered in Taizhou City, Jiangsu Province, owns over 20 subsidiaries with over 16000 employees in total located in Taizhou, Beijing, Shanghai, Nanjing, Guangzhou, Chengdu, Suzhou, Changzhou, etc. Sales network covers all the provinces, cities and autonomous regions except Taiwan. YRPG always devotes itself to offer products and services of high quality and efficiency to the society, fulfilling the core values of “Create High Quality, Benefit the Public, Keep Continuous Innovation, Pursue Consummate Excellence”. From 2014 to 2020, YRPG ranked the first place among Top 100 Enterprises of China Pharmaceutical Industry for 6 consecutive years published by Ministry of Industry and Information Technology of China. In 2016, YRPG achieved the double winners of China Brand Evaluation in bio-pharmaceutical field for both Brand Value and Brand Power. In 2019, YRPG achieved the double winners in China pharmaceutical field again with Brand Value of RMB 42.869 billion and Brand Power of 980 points. In the development of 5 decades, YRPG was also honored Nomination of China Quality Award, Global Performance Excellence Award (World Class), National Enterprise of “Keeping Promise & Honoring Contracts”, etc.